2 to 3 times
women are more likely
to develop MS than men.
2.8 million
people worldwide
are living with Multiple Sclerosis.
40%
of people with MS will experience significant disability
within 10 to 15 years of diagnosis.
In multiple sclerosis, our immune system attacks our own nerves. Antibodies destroy their covers and create scars. This disrupts the nerve signals and causes the symptoms of MS.
Optic Issues
Vestibular symptoms
Bulbar dysfunction
Motor Problems
Sensory Issues
Urinary and bowel symptoms
Cognitive symptoms
Psychiatric symptoms
To date, there is no cure for Multiple Sclerosis that leads to complete disease remission. Current approaches focus on delay, recovery and symptom management.
This innovative approach targets the two key systems affected by Multiple Sclerosis: the immune system and the nervous system.
Selectively targets, regulates MS autoantibodies and boosts the immune system with engineered patient cells.
Detects signature microRNA biomarkers in myelin forming cells and releases microRNAs with restorative qualities using a unique molecular structure.
